We are a passionate team of advocates for revolutionary advances in medical technology.
Former U.S. Department of Health and Human Services (HHS) Chief Information Officer (CIO) and Deputy Assistant Secretary for Information Technology Frank Baitman has deep information technology (IT) expertise is in the healthcare and government sectors. Mr. Baitman is currently a consultant and advisor for several technology firms across the U.S., and sits on a number of advisory boards. Between 2012 and 2015, while he was with HHS, Mr. Baitman was responsible for leading the strategic direction and management of IT for the nation’s second largest cabinet agency with ten operating divisions. He was also responsible for developing a unified approach to cybersecurity and privacy for the agency, by consolidating incident response and leading the Department’s privacy incidence response team. Mr. Baitman was also a champion for utilizing cloud-based services; through his efforts HHS led the federal government in securing multiple cloud service providers, and in establishing a cloud-based innovation platform that is employed at HHS’ operating divisions.
Prior to joining HHS, Mr. Baitman was a White House Entrepreneur-in-Residence (EIR) at the U.S. Food and Drug Administration (FDA), and the chief information officer at the U.S. Social Security Administration from 2009 to 2011. Before holding these positions of leadership with the U.S. government, he was the President of Petards Inc., Research Director for the Institute for the Future, and Director of Corporate Strategy with IBM, where he created new business units in the Life Sciences and Pervasive Computing, and commercialized emerging technologies.
Scott Cousino has over 30 years of investment banking experience primarily focused on the healthcare sector where he has completed a wide range of M&A, strategic advisory and capital markets transactions. Mr. Cousino is currently a Managing Director at England & Company where he originates and executes merger and acquisition, financing and advisory assignments for middle market companies in a range of industries. His primary focus is currently on Healthcare Services and Healthcare IT companies, including Managed Care and Disease Management and all aspects of Post-Acute care.
Prior to England & Company, Mr. Cousino was a Managing Director at Stifel Nicolaus Weisel, where he served as Head of its Healthcare Investment Banking Group. In this role his primary responsibility was establishing and maintaining long-term client relationships across a broad spectrum of healthcare companies over an extended period of time and his calling efforts focused on public and leading private companies in targeted sectors as well as relevant financial sponsors. He also served as a Managing Director and Head of Healthcare Investment Banking at Legg Mason prior to its acquisition by Stifel in 2005. In addition, Mr. Cousino served as Chairman of the Fairness Opinion Committee at Stifel and Legg Mason for over ten years.
Mr. Cousino earned his BBA and MBA in Finance from the College of William and Mary. He has been active on numerous non-profit boards and currently serves on the Finance Committee of the Y of Central Maryland.
Krista Drobac has nearly twenty years of experience in federal and state government, and in public affairs. She provides strategic advice to a range of companies on the market dynamics in Medicaid, Medicare, the individual market, and provider market such as CPC+, ACOs, and bundled payment. She has represented clients across the spectrum, including insurance companies, PBMs, providers and digital technology companies.
She was previously the director of the Health Division at the National Governors Association’s Center for Best Practices where she directed technical assistance for governors’ health advisors in the areas of health insurance exchanges, Medicaid, health IT, delivery system reform and public health programs.
Prior to NGA, she was a Senior Advisor at the Center for Medicare and Medicaid Services where she worked in Medicaid and was one of the original members of the team that launched the Center for Consumer Information and Insurance Oversight (CCIIO). During her time at CCIIO, she was a senior member of the team that published the first rules related to the Affordable Care Act.
Ms. Drobac has also served as Deputy Director of the Illinois Department of Healthcare and Family Services where she spearheaded efforts to establish a health information exchange and a pay for performance program for primary care physicians.
She also spent five years on Capitol Hill where she was a health advisor to the Majority Whip Senator Dick Durbin, and a John Heinz Senate Fellow for Senator Debbie Stabenow. While in Senator Durbin’s office, she led efforts around medical malpractice, insurance reform for small business and dietary supplements.
Krista holds a BA from University of Michigan and an MPP from the Harvard University Kennedy School of Government.
Theresa is an internationally recognized UX designer and thought leader. Her top selling O’Reilly books, Designing Web Interfaces, co-authored with Bill Scott, and the Mobile Design Pattern Gallery have helped thousands of IT professionals advance their design skills and create better experiences. As an active UX practitioner, she's led the design for more than 150 live products in the past 15 years and was named one of the Top Designers in Technology by Business Insider.
As an advisor for WellDoc, Theresa collaborates with the Product, Development, Design and Marketing teams to incorporate best practices and innovative design thinking to the product suite.
Daniel Rosenberg is one of the founders of the user experience field, having contributed to several of the first books in the field. He has over 3 decades of software designer experience and has invented many commonly used UX concepts and patterns. He is also known as a global design leader having served as the design SVP for both Oracle and SAP for a combined duration of 18 years.
Dan is an adjunct professor at San Jose State University and consults through rCDOUX.com. His clients include both startups and publically held companies in the medical, consumer, big data and enterprise software areas. He has been advising with WellDoc for approximately 2 years.
Dan is a forum editor and blogger for ACM interactions magazine and is also a frequently invited keynote speaker at user experience conferences around the world.
Michael Stocker, MD
Michael Stocker, MD serves as the Chairman of the Board of the New York City Health and Hospitals Corporation (HHC), the largest municipal hospital and health care system in the country, serving 1.3 million New Yorkers annually. Prior to this role, he served as executive vice president of WellPoint, chief executive officer of Empire Blue Cross and Blue Shield, president of Cigna Health Plans, and general manager of U.S. Healthcare. He has also held many board positions including being a Board Member at FAIR Health and Coventry Health Care, which was recently acquired by Aetna. Dr. Stocker also frequently volunteers his expertise in healthcare administration across public and private organizations. Presently he is a board member of the Arthur Ashe Institute for Urban Health as well as the United Hospital Fund and he previously served as a member of the New Jersey Governor's Health Care Cost Reduction Advisory Committee and the National Committee for Quality Assurance (NCQA).
Earlier in his career, Dr. Stocker was a practicing physician at Cook County Hospital in Chicago and a medical director at Anchor HMO at Rush Presbyterian St. Luke's Medical Center. Dr. Stocker was educated at the University of Notre Dame and received his MD from the Medical College of Wisconsin. He received his postgraduate training at the Mayo Clinic and the University of California and is board certified in Internal Medicine and Family Practice. Dr. Stocker also holds a Master's degree in Public Health from the University of Michigan and he served his country in the United States Army.
H. Thomas Watkins
H. Thomas Watkins served as the President and Chief Executive Officer of Human Genome Sciences, Inc. and as a member of its Board of Directors from 2005 until August 2012, when Human Genome Sciences, Inc. was acquired by GlaxoSmithKline. Prior to his tenure at Human Genome Sciences, Inc., Mr. Watkins served as President of TAP Pharmaceutical Products, Inc. Mr. Watkins previously held a series of executive positions over the course of nearly twenty years with Abbott Laboratories. Mr. Watkins also serves on the Board of Directors of the Biotechnology Industry Organization (BIO), and has served as Chair of the BIO Board of Directors. Previously he was appointed by Governor O'Malley to Chair the Life Sciences Advisory Board for the state of Maryland. He holds a B.B.A. from the College of William and Mary and an M.B.A from the University of Chicago Graduate School of Business.